USAQOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

QHSLab, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.32+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $7.38M
P/E (TTM): –
Dividend yield: –

QHSLab, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Depreciation & Amortization	0.09	0.15	0.15	0.13	0.04	0	–	–	–	–	–	–	–	–	–	–
Stock-Based Compensation	0	0	0.01	0.03	0.04	0.01	–	–	–	–	–	–	–	–	–	–
Other Non-Cash Items	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	–
Change in Accounts Receivable	0.00	-0.13	-0.03	0.01	-0.01	-0.06	–	–	–	–	–	–	–	–	–	–
Change in Inventory	0.01	-0.02	0.03	0.01	0.03	-0.10	–	–	–	–	–	–	–	–	–	–
Change in Accounts Payable	-0.01	0.26	-0.01	0.07	-0.13	0.14	0.02	-0.01	0.01	0.01	0.01	–	–	0.01	0.01	–
Operating Cash Flow	-0.18	0.14	-0.16	-0.35	-0.35	-0.17	-0.13	-0.04	0.00	-0.01	-0.04	-0.02	-0.01	0.00	0.00	–
Investing Cash Flow	–	–	–	-0.04	-0.15	-0.03	–	–	–	–	–	0	0	0	0	0
Stock Issued	0.50	–	–	0.05	0.03	–	0.00	–	–	–	–	–	–	–	–	–
Financing Cash Flow	0.30	-0.04	0.03	0.28	0.70	0.27	0.16	0.04	0.00	0.01	0.04	0.02	0.01	0.00	0.00	–
Net Change in Cash	0.48	0.11	-0.13	-0.11	0.19	0.07	0.02	–	–	–	–	0	0	–	–	–
Interest Paid	0.08	0.25	0.06	0.07	0.04	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 67.7%
Operating margin: 2.7%
Net margin: -13.0%
Return on equity, FY2025: -89.9%

Financial strength

Current ratio: 1.82
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 84.5%

Valuation

P/E ratio: –
Price to sales: 2.45
Price to book: 4.74
Dividend yield: –